Sichuan News Net – First Screen News Chengdu, May 26 (Reporter Li Dan) On the 26th, the reporter learned from the Sichuan Provincial Medical Insurance Bureau that in accordance with the “On Doing a Good Job in the National Centralized Drug Procurement (Insulin Special) Drug Centralized and Volume Procurement The “Notice on the Implementation of the Selection Results” requires that the results of the special centralized procurement of insulin will be implemented in Sichuan from May 27, 2022.
The special collection of insulin covers the second- and third-generation insulins commonly used in clinical practice. A total of 16 generic varieties from 11 companies were selected, including mealtime human insulin, basal human insulin, premixed human insulin, and mealtime insulin similar There are six categories: basal insulin analogs, premixed insulin analogs. The price of the selected products dropped by an average of 48%, with a maximum drop of 73%. Taking insulin glargine, which is commonly used in clinics, as an example, the average price has dropped from 180 yuan per bottle to about 70 yuan per bottle, and each diabetic patient can save about 4,000 yuan per year. In the first year, the province agreed to purchase more than 6.8 million pieces, and it is expected to save more than 298 million yuan in procurement funds.
The special centralized procurement of insulin is the first time that the centralized drug procurement organized by the state has expanded to the field of biological drugs, and it is an important milestone in the process of centralized procurement reform. This special collection of insulin not only effectively reduces the cost burden of diabetic patients, but also improves the accessibility of advanced treatment drugs for diabetic patients.
（Li Dan）
(Sichuan News Network)